ologen® Collagen Matrix (CM) is an artificial extracellular matrix (ECM) specifically configured to support repair in connective and epithelial ocular tissue. The device is constructed so as to minimize random growth of fibroblasts and instead to allow them to grow through the pores in the matrix. ologen® CM is a biodegradable scaffold matrix, inducing a regenerative non-scarring wound healing process without using anti-fibrotic agents. For application in glaucoma filtration surgery, ologen® CM is designed to prevent scar formation (subconjunctival and scleral flap scarring is the major risk factor for failure of trabeculectomy). After implanting the ologen® CM on top of the scleral flap in the subconjunctival space, a functional bleb can be created.
The aim of the present study is to determine the effectiveness of the ologen® CM and reduce wound scarring, thereby increasing success of trabeculectomy without side effects of MMC. A means of producing better success rate and reduced complications is the purpose of ologen® Collagen Matrix for the aid of glaucoma surgery.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or over
Uncontrolled open-angle glaucoma
Subject is willing to sign informed consent
Subject is able and willing to complete post-operative follow-up requirements
You may not be if
Inflammatory eye diseases
Angle-closure glaucoma
Secondary glaucoma with anatomical malformations of the eye
Subjects having single functional eye
Previous conjunctival surgery
Known allergic reactions to ingredients of ologen Collagen Matrix
Excessive myopia (axial length (AL)\> 27 mm or more than -10 diopters)